| Biotechnology Industry | Healthcare Sector | Prof. Osmo Antero Suovaniemi M.D., Ph.D. CEO | XHEL Exchange | FI0009005482 ISIN |
| Finland Country | 47 Employees | - Last Dividend | - Last Split | - IPO Date |
Biohit Oyj is a pioneering biotechnology company based in Helsinki, Finland, established in 1988. The company focuses on manufacturing and marketing a broad range of diagnostic products and systems worldwide. These offerings are tailored for use across various sectors including research institutions, healthcare, and industry. Biohit Oyj's innovative solutions are designed to address the critical needs in diagnostic analysis, particularly in understanding and managing gastrointestinal diseases, vitamin deficiencies, and conditions like celiac disease and lactose intolerance. Additionally, Biohit Oyj is at the forefront of developing acetaldehyde-binding products aimed at reducing acetaldehyde exposure, which is implicated in several health conditions.